Beovu & Recarbrio Among Five Drugs On Track For EU-Wide Approval
No Decision On Celgene/Agios Pharmaceuticals’ AML Drug Enasidenib
Executive Summary
Five new drugs have been recommended for EU approval at the latest meeting of European Medicines Agency’s drug evaluation committee.
You may also be interested in...
2019 Sees Decline In EMA Drug Approval Recommendations
The number of positive opinions given by the EMA’s CHMP has fallen to 66 this year from 84 in 2018.
EMA Prepares Approval Verdict On Beovu, Idhifa, Recarbrio
Products from Novartis, Celgene and Merck could get an EU approval recommendation at this week's CHMP meeting.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.